Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
or

Nuvation Bio Inc (NUVB)

Nuvation Bio Inc (NUVB)
1.6800 x 400 1.7900 x 1,100
Post-market by (Cboe BZX)
1.7500 -0.0100 (-0.57%) 04/01/25 [NYSE]
1.6800 x 400 1.7900 x 1,100
Post-market 1.7500 unch (unch) 16:01 ET
Quote Overview for Tue, Apr 1st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.6600
Day High
1.7850
Open 1.7600
Previous Close 1.7600 1.7600
Volume 2,923,500 2,923,500
Avg Vol 2,988,830 2,988,830
Stochastic %K 8.64% 8.64%
Weighted Alpha -54.64 -54.64
5-Day Change -0.1900 (-9.79%) -0.1900 (-9.79%)
52-Week Range 1.6600 - 3.9700 1.6600 - 3.9700
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 596,075
  • Shares Outstanding, K 338,679
  • Annual Sales, $ 7,870 K
  • Annual Income, $ -567,940 K
  • EBIT $ -593 M
  • EBITDA $ -592 M
  • 60-Month Beta 1.47
  • Price/Sales 78.29
  • Price/Cash Flow N/A
  • Price/Book 1.33

Options Overview Details

View History
  • Implied Volatility 223.49% ( +32.41%)
  • Historical Volatility 77.29%
  • IV Percentile 98%
  • IV Rank 94.84%
  • IV High 234.17% on 06/24/24
  • IV Low 26.99% on 10/23/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 117
  • Volume Avg (30-Day) 445
  • Put/Call OI Ratio 1.46
  • Today's Open Interest 8,804
  • Open Int (30-Day) 9,200

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.16
  • Number of Estimates 4
  • High Estimate -0.14
  • Low Estimate -0.17
  • Prior Year -0.07
  • Growth Rate Est. (year over year) -128.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6600 +5.42%
on 04/01/25
Period Open: 1.9700
2.4200 -27.69%
on 03/12/25
-0.2200 (-11.17%)
since 02/28/25
3-Month
1.6600 +5.42%
on 04/01/25
Period Open: 2.6600
3.4550 -49.35%
on 01/07/25
-0.9100 (-34.21%)
since 12/31/24
52-Week
1.6600 +5.42%
on 04/01/25
Period Open: 3.6900
3.9700 -55.92%
on 07/31/24
-1.9400 (-52.57%)
since 04/01/24

Most Recent Stories

More News
This Biotech Stock Insider is Buying Shares, Should You?

This Nuvation Bio board member and longtime biotech industry insider carried out his first purchase since his appointment in January.

$NASX : 17,449.89 (+0.87%)
TNDM : 18.73 (-2.24%)
$SPX : 5,633.07 (+0.38%)
NUVB : 1.7500 (-0.57%)
VRTX : 484.74 (-0.02%)
SNY : 54.34 (-2.02%)
2 'Strong Buy'-Rated Penny Stocks That Could Skyrocket 192% to 205% in 2025

A promising product portfolio could boost this biotech company’s financials in the near future.

STLA : 11.09 (-1.07%)
ACHR : 6.96 (-2.11%)
$SPX : 5,633.07 (+0.38%)
NUVB : 1.7500 (-0.57%)
3 Standout Stocks Under $10 With 86% Upside Potential or More

As the chances for a September rate cut grow even stronger, these three penny stocks can emerge as substantial wealth creators.

AMZN : 192.17 (+1.00%)
AAPL : 223.19 (+0.48%)
NVDA : 110.15 (+1.63%)
OPAL : 1.7000 (-7.61%)
OCUL : 6.54 (-10.78%)
NUVB : 1.7500 (-0.57%)
Biotech Sector Advances in Pancreatic Cancer Research

USA News Group – Known as one of the most deadly forms of cancer, pancreatic cancer still has the highest mortality rate of all major cancers today. However, researchers and the biotech sector are working...

BRX : 26.52 (-0.11%)
ONCY : 0.5270 (-4.18%)
ONC.TO : 0.77 (-2.53%)
NVS : 109.61 (-1.68%)
IBRX : 2.96 (-1.66%)
ACRS : 1.4800 (-3.27%)
NUVB : 1.7500 (-0.57%)
Biotech’s Role in Addressing the Pancreatic Cancer Emergency

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:NVX),(NASDAQ:IBRX),(NASDAQ:ACRS),(NYSE:NUVB) EQNX::TICKER_END

NVX : 1.1000 (-3.51%)
ONCY : 0.5270 (-4.18%)
ONC.TO : 0.77 (-2.53%)
NVS : 109.61 (-1.68%)
IBRX : 2.96 (-1.66%)
ACRS : 1.4800 (-3.27%)
NUVB : 1.7500 (-0.57%)
Nuvation Bio Reports First Quarter 2023 Financial Results and Provides Business Update

Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today reported its financial...

NUVB : 1.7500 (-0.57%)
Nuvation Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today reported financial...

NUVB : 1.7500 (-0.57%)
Nuvation Bio Doses First Patient in Phase 1b Combination Study of NUV-868

Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced it has dosed...

NUVB : 1.7500 (-0.57%)
Nuvation Bio Reports Third Quarter 2022 Financial Results and Provides Business Update

Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today reported its financial...

NUVB : 1.7500 (-0.57%)
Nuvation Bio Reports Second Quarter 2022 Financial Results and Provides Business Update

Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today reported its financial...

NUVB : 1.7500 (-0.57%)

Business Summary

Nuvation Bio Inc. is a biopharmaceutical company. It engages in developing differentiated and novel therapeutic candidates for unmet needs in oncology. Nuvation Bio Inc., formerly known as Panacea Acquisition Corp., is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 1.9283
2nd Resistance Point 1.8567
1st Resistance Point 1.8033
Last Price 1.7500
1st Support Level 1.6783
2nd Support Level 1.6067
3rd Support Level 1.5533

See More

52-Week High 3.9700
Fibonacci 61.8% 3.0876
Fibonacci 50% 2.8150
Fibonacci 38.2% 2.5424
Last Price 1.7500
52-Week Low 1.6600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies